• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克因子1(HSF1)的转录活性受IER5和蛋白磷酸酶2A/B55调节。

HSF1 transcriptional activity is modulated by IER5 and PP2A/B55.

作者信息

Ishikawa Yukio, Kawabata Shotaro, Sakurai Hiroshi

机构信息

Division of Health Sciences, Kanazawa University Graduate School of Medical Science, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 920-0942, Japan.

Division of Health Sciences, Kanazawa University Graduate School of Medical Science, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 920-0942, Japan.

出版信息

FEBS Lett. 2015 Apr 28;589(10):1150-5. doi: 10.1016/j.febslet.2015.03.019. Epub 2015 Mar 26.

DOI:10.1016/j.febslet.2015.03.019
PMID:25816751
Abstract

Heat shock factor 1 (HSF1) is the master transcriptional regulator of chaperone genes. HSF1 regulates the expression of the immediate-early response gene IER5, which encodes a protein that has roles in the stress response and cell proliferation. Here, we have shown that IER5 interacts with protein phosphatase 2A (PP2A) and its B55 regulatory subunits. Expression of IER5 and B55 in cells leads to HSF1 dephosphorylation and activation of HSF1 target genes. The B55 subunits directly bind to HSF1. These results suggest that IER5 functions as a positive feedback regulator of HSF1 and that this process involves PP2A/B55 and HSF1 dephosphorylation.

摘要

热休克因子1(HSF1)是伴侣蛋白基因的主要转录调节因子。HSF1调节即时早期反应基因IER5的表达,IER5编码一种在应激反应和细胞增殖中起作用的蛋白质。在此,我们已表明IER5与蛋白磷酸酶2A(PP2A)及其B55调节亚基相互作用。IER5和B55在细胞中的表达导致HSF1去磷酸化并激活HSF1靶基因。B55亚基直接与HSF1结合。这些结果表明IER5作为HSF1的正反馈调节因子发挥作用,并且该过程涉及PP2A/B55和HSF1去磷酸化。

相似文献

1
HSF1 transcriptional activity is modulated by IER5 and PP2A/B55.热休克因子1(HSF1)的转录活性受IER5和蛋白磷酸酶2A/B55调节。
FEBS Lett. 2015 Apr 28;589(10):1150-5. doi: 10.1016/j.febslet.2015.03.019. Epub 2015 Mar 26.
2
Immediate-early response 5 (IER5) interacts with protein phosphatase 2A and regulates the phosphorylation of ribosomal protein S6 kinase and heat shock factor 1.即刻早期反应蛋白5(IER5)与蛋白磷酸酶2A相互作用,并调节核糖体蛋白S6激酶和热休克因子1的磷酸化。
FEBS Lett. 2015 Nov 30;589(23):3679-85. doi: 10.1016/j.febslet.2015.10.013. Epub 2015 Oct 20.
3
IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis.IER5产生一种新型的低磷酸化活性形式的HSF1,并促进肿瘤发生。
Sci Rep. 2016 Jan 12;6:19174. doi: 10.1038/srep19174.
4
Heat-induced expression of the immediate-early gene IER5 and its involvement in the proliferation of heat-shocked cells.热诱导即刻早期基因IER5的表达及其在热休克细胞增殖中的作用。
FEBS J. 2015 Jan;282(2):332-40. doi: 10.1111/febs.13134. Epub 2014 Nov 17.
5
IER family proteins are regulators of protein phosphatase PP2A and modulate the phosphorylation status of CDC25A.IER 家族蛋白是蛋白磷酸酶 PP2A 的调节因子,调节 CDC25A 的磷酸化状态。
Cell Signal. 2019 Mar;55:81-89. doi: 10.1016/j.cellsig.2018.12.012. Epub 2018 Dec 30.
6
Nuclear import of IER5 is mediated by a classical bipartite nuclear localization signal and is required for HSF1 full activation.IER5 的核输入是由经典的双肽核定位信号介导的,这对于 HSF1 的完全激活是必需的。
Exp Cell Res. 2020 Jan 1;386(1):111686. doi: 10.1016/j.yexcr.2019.111686. Epub 2019 Nov 6.
7
PP2A-AMPKα-HSF1 axis regulates the metal-inducible expression of HSPs and ROS clearance.PP2A-AMPKα-HSF1 轴调节 HSPs 的金属诱导表达和 ROS 清除。
Cell Signal. 2014 Apr;26(4):825-32. doi: 10.1016/j.cellsig.2014.01.002. Epub 2014 Jan 8.
8
PP2A-B55 and its adapter proteins IER2 and IER5 regulate the activity of RB family proteins and the expression of cell cycle-related genes.蛋白磷酸酶2A-B55及其衔接蛋白IER2和IER5调节RB家族蛋白的活性以及细胞周期相关基因的表达。
FEBS J. 2023 Feb;290(3):745-762. doi: 10.1111/febs.16612. Epub 2022 Sep 12.
9
Regulation of the stability and activity of CDC25A and CDC25B by protein phosphatase PP2A and 14-3-3 binding.蛋白磷酸酶 PP2A 和 14-3-3 结合对 CDC25A 和 CDC25B 的稳定性和活性的调节。
Cell Signal. 2019 Feb;54:10-16. doi: 10.1016/j.cellsig.2018.11.017. Epub 2018 Nov 20.
10
PP2A and its adapter protein IER5 induce the DNA-binding ability and target gene expression of E2F1 via dephosphorylation at serine 375.蛋白磷酸酶 2A(PP2A)及其衔接蛋白 IER5 通过去磷酸化 E2F1 第 375 位丝氨酸来诱导其 DNA 结合能力和靶基因表达。
Biochim Biophys Acta Gene Regul Mech. 2023 Sep;1866(3):194960. doi: 10.1016/j.bbagrm.2023.194960. Epub 2023 Jul 17.

引用本文的文献

1
IER5 Negatively Regulates Cdc25B Expression in HeLa Cells After Gamma Ray Irradiation.IER5在γ射线照射后对HeLa细胞中Cdc25B的表达起负调控作用。
Biomed Res Int. 2025 Aug 14;2025:5644318. doi: 10.1155/bmri/5644318. eCollection 2025.
2
HSF1 Activation Mechanisms, Disease Roles, and Small Molecule Therapeutics.热休克因子1的激活机制、在疾病中的作用及小分子疗法
Int J Biol Sci. 2025 Apr 28;21(8):3351-3378. doi: 10.7150/ijbs.110447. eCollection 2025.
3
Molecular mechanism of PP2A/B55α phosphatase inhibition by IER5.IER5抑制PP2A/B55α磷酸酶的分子机制
Cell Chem Biol. 2025 Apr 17;32(4):631-642.e7. doi: 10.1016/j.chembiol.2025.03.004. Epub 2025 Apr 9.
4
CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology.细胞功能综合分析工具(CellFIE):将通路发现与扰动的集中分析相结合,揭示亨廷顿病的通路,包括神经元发育和形态的遗传修饰因子。
bioRxiv. 2025 Feb 22:2025.02.19.639023. doi: 10.1101/2025.02.19.639023.
5
The PP2A regulator IER5L supports prostate cancer progression.IER5L 作为一种 PP2A 调节因子,可促进前列腺癌的进展。
Cell Death Dis. 2024 Jul 18;15(7):514. doi: 10.1038/s41419-024-06907-z.
6
Potential roles for mitochondria-to-HSF1 signaling in health and disease.线粒体至热休克因子1信号通路在健康与疾病中的潜在作用。
Front Mol Biosci. 2023 Dec 18;10:1332658. doi: 10.3389/fmolb.2023.1332658. eCollection 2023.
7
Molecular Mechanism of PP2A/B55α Phosphatase Inhibition by IER5.IER5对PP2A/B55α磷酸酶的抑制作用的分子机制
bioRxiv. 2024 Aug 26:2023.08.29.555174. doi: 10.1101/2023.08.29.555174.
8
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition.对抗PD-1定向免疫检查点抑制耐药的黑色素瘤患者的医疗需求和治疗选择
Cancers (Basel). 2023 Jun 30;15(13):3448. doi: 10.3390/cancers15133448.
9
p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment.癌症治疗中使用的化学放射治疗药物耐药背后的p53依赖性细胞保护机制
Cancers (Basel). 2023 Jun 28;15(13):3399. doi: 10.3390/cancers15133399.
10
Targeting HSF1 for cancer treatment: mechanisms and inhibitor development.靶向 HSF1 治疗癌症:机制与抑制剂开发。
Theranostics. 2023 Apr 17;13(7):2281-2300. doi: 10.7150/thno.82431. eCollection 2023.